Funding News

LUXEMBOURG--(BUSINESS WIRE)--Cullinan Holdco SCSp (the “Issuer”, and together with its subsidiaries, “Graanul” or the “Group”) is pleased to announce that it has entered into a transaction support agreement (the “Transaction Support Agreement”) with noteholders (the “Participating Holders”) collectively representing 50% of the aggregate principal amount of its (i) 4.625% Sustainability-Linked Senior Secured Notes due 2026 (the “Existing Fixed Rate Notes”) and (ii) Sustainability-Linked Senior S...

TORONTO--(BUSINESS WIRE)--Accord Announces Banking Facility Update...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that it is proposing to raise up to $2,500,000 by way of a Non-Brokered Private Placement of up to 33,333,334 Units at $0.075 per Unit (“Unit”). Each Unit will be comprised of One (1) fully paid common share and One-half (1/2) of a Share Purchase Warrant; each whole Share Purchase Warrants (“Warrant(s)”) will be exercisable to purchase One (1) further Common Share at the price...

PHOENIX--(BUSINESS WIRE)--Sprouts Farmers Market, Inc. (Nasdaq: SFM) today announced the closing of a $600 million revolving credit facility (the “Revolving Credit Facility”) under a credit agreement dated as of July 25, 2025. The Revolving Credit Facility refinances the company’s previous $700 million revolving credit facility, which was replaced in connection with Sprouts’ entry into the Revolving Credit Facility. The Revolving Credit Facility contains terms and conditions substantially simil...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Venova Technologies, Inc., a women-led startup developing a novel long-acting, hormone-free and copper-free female birth control device, has been awarded a $2.23M Small Business Innovation Research (SBIR) Phase II Grant from the National Institutes of Health (NIH). The SBIR program is a highly competitive, awards-based program designed to stimulate technological innovations developed by U.S. small businesses on a path to commercialization. This Phase II award...

LEAWOOD, Kan.--(BUSINESS WIRE)--AMC Entertainment Holdings, Inc. (NYSE: AMC) (“AMC” or the “Company”) today announced the successful completion of a series of previously announced debt refinancing transactions with key creditor groups, including certain holders of its 7.5% Senior Secured Notes due 2029 (the “Consenting 7.5% Noteholders”), certain holders of Muvico, LLC’s 6.00%/8.00% Senior Secured Exchangeable Notes due 2030 (the “Consenting Exchangeable Noteholders”) and certain lenders of AMC...

MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, and designed for both commercial and government applications, today announced the pricing of $500.0 million aggregate principal amount of convertible senior notes due 2032 (the “Notes”) in a private offering (the “Notes Offering”) to persons reasonably believed to be qualified instit...

MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, and designed for both commercial and government applications, today announced the pricing of a cash repurchase (the “Repurchase”) of $135.0 million aggregate principal amount of its 4.25% convertible senior notes due 2032 (the “Existing Notes”) and its offering of approximately 5.8 m...

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced that it has executed financing to provide further working capital and support its ongoing business operations. The Company entered into a securities purchase agreement for a registered direct offering with two institutional investors, providing for the issuance of common stock of ImmunityBio as well as warrants for the purchase of additional shares of common stock of Immunity...

HUMMELSTOWN, Pa.--(BUSINESS WIRE)--Targepeutics and Yuvaan Tiwari Foundation form relationship to advance GB13 into clinical trials for pediatric brain cancer....